Navigating HER2+ Breast Cancer Treatment: A Patient's Journey
Panelists discuss how a patient navigated her treatment journey at Memorial Sloan Kettering (MSK), detailing the specific treatments received, her responses to those treatments, and her active participation in the shared decision-making process regarding her care.
EP: 1.Overview of HER2 Breast Cancer
EP: 2.HER2+ Breast Cancer Diagnosis: Insights From Patients and Clinicians
EP: 3.Coordinating Care for HER+ Breast Cancer Patients: A Multidisciplinary Approach
EP: 4.Multidisciplinary Care of HER2+ Breast Cancer: A Patient Perspective
EP: 5.Tailoring Patient Education and Resources in HER2+ Breast Cancer
Now Viewing
EP: 6.Navigating HER2+ Breast Cancer Treatment: A Patient's Journey
EP: 7.Navigating Systemic Therapy Options in HER2+ Breast Cancer
EP: 8.Key Insights from the HER2CLIMB Trial
EP: 9.Key Insights From the DEBBRAH and HER2CLIMB-02 Studies
EP: 10.BRIDGET Trial: Strategies in Maintenance Therapy for HER2+ Breast Cancer with Brain Metastases
EP: 11.Preparing Patients for Treatment: Education, Administration and Adverse Effect Management in HER2+ Breast Cancer
EP: 12.Patient Perspectives on Managing Adverse Effects from Capecitabine, Trastuzumab, and Tucatinib
EP: 13.Comprehensive Supportive Care for Metastatic HER2+ Breast Cancer
EP: 14.Patient Perspective: Key Aspects of Supportive Care in the HER2+ Breast Cancer Journey
EP: 15.Future Perspectives in HER2+ Breast Cancer
EP: 16.Closing Thoughts: Key Messages for Clinicians and Patients in the Treatment of HER2+ Breast Cancer
EP: 17.Discussing, Managing, and Treating HER2+ Breast Cancer From the Patient’s Perspective
- Dr Iyengar asks Dorian Nygard: Dorian, can you walk us through your treatment journey at MSK?
- What specific treatments did you receive and how did you respond
- How did you participate in the shared decision-making process for your treatment?
Recent Videos
Related Content
